Guillem Llorens-Garcia
Valencia, VC, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Organobodies: a robust and size-controllable system for generating scalable hiPSC-derived liver organoids for drug toxicity screening.
Journal: Biofabrication
Published: December 05, 2025
Drug-Induced Fatty Liver Disease (DIFLD): A Comprehensive Analysis of Clinical, Biochemical, and Histopathological Data for Mechanisms Identification and Consistency with Current Adverse Outcome Pathways.
Journal: International journal of molecular sciences
Published: March 25, 2024
A robust reprogramming strategy for generating hepatocyte-like cells usable in pharmaco-toxicological studies.
Journal: Stem cell research & therapy
Published: September 21, 2022
Automated Generation of hiPSC-Derived Hepatic Progeny by Cost-Efficient Compounds.
Journal: Stem cells (Dayton, Ohio)
Published: September 07, 2022
Modeling a Novel Variant of Glycogenosis IXa Using a Clonal Inducible Reprogramming System to Generate "Diseased" Hepatocytes for Accurate Diagnosis.
Journal: Journal of personalized medicine
Published: June 06, 2022
A Novel UPLC-MS Metabolomic Analysis-Based Strategy to Monitor the Course and Extent of iPSC Differentiation to Hepatocytes.
Journal: Journal of proteome research
Published: January 04, 2022
Derivation of healthy hepatocyte-like cells from a female patient with ornithine transcarbamylase deficiency through X-inactivation selection.
Journal: Scientific reports
Published: July 12, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026